Sunday, 16 August 2026European Markets
ExploreSearch
ViaNews EU
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Platforms Move to Shore Up Trust as Leadership Shifts and AI-Adjacent Markets Wobble
Major AI and media platforms are converging on trust and accountability measures — Anthropic's Claude adding watermarks, Spotify labeling AI artists — just as OpenAI loses special-projects lead Brad Lightcap and Meta's Zuckerberg publishes a defensive manifesto on AI's societal role. In parallel, AI-adjacent financial dynamics are surfacing real stress: Wall Street firms are paying for privileged early access to Trump's Truth Social posts for trading edge, while Trump Media itself reports a $238M loss driven by falling crypto holdings, highlighting how information asymmetry and speculative digital assets are becoming entangled with AI-era platforms.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts report JPMorgan Chase & Co.'s revenue for the same fiscal period (FY 2025) with the same observation date (2025-12-31), but with different values: $182.447 billion vs. $185 billion. The ~1.4% difference ($2.553 billion) is too large to be explained by rounding alone and represents conflicting data for the identical time period.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,809
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,809 facts checked against source5,205 source documents archived
Work with this data → vianewsagency.com
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 15, 2025

4 Medical Device Stocks to Buy for Healthy Returns in 2026

View original at finance.yahoo.com
4 Medical Device Stocks to Buy for Healthy Returns in 2026 2025 brought ups and downs for the MedTech industry. Under President Trump’s second term, shifting trade policies, including new and heightened threats of tariffs, sanctions and other restrictions, created significant uncertainties…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Boston Scientific carries a Zacks Rank #2 (Buy)

    80% confidence

  • For 2026, Intuitive Surgical revenues are expected to grow 14.3%, whereas earnings per share are expected to rise 11.2%

    80% confidence

  • For 2026, Boston Scientific revenues and EPS are expected to jump 11.1% and 13.6%, respectively

    80% confidence

  • Insulet holds a Zacks Rank #2 (Buy)

    80% confidence

  • M&A activity shifted toward fewer but larger deals, with average transaction size rising 11% from 2024

    80% confidence

  • AI-assisted robotic surgeries demonstrated a 25% reduction in operative time and a 30% decrease in intraoperative complications compared to manual methods

    80% confidence

  • IDEXX Laboratories carries a Zacks Rank #2 (Buy)

    80% confidence

  • The MedTech industry generated $584 billion in revenues in 2025, marking its seventh consecutive year of top-line growth

    80% confidence

  • IDEXX's 2026 revenues and EPS are likely to increase 8.9% and 11.6%, respectively

    80% confidence

  • IDEXX plans to expand the Cancer Dx franchise in 2026 by adding mast cell tumor and introducing it in international markets

    80% confidence

  • The digital twins market is forecasted to expand at a 16.6% CAGR between 2025 and 2032

    80% confidence

  • More Omnipod 5 rollouts are planned in 2026, while Libre 3 integration in the United States remains on track for the first half of 2026

    80% confidence

  • The global medical device market is expected to expand at a CAGR of 5.94% from 2026 to 2035

    80% confidence

  • Through September 2025, the FDA's list of AI-enabled device authorizations included more than 250 devices, with Radiology taking the lead

    80% confidence

  • Intuitive Surgical carries a Zacks Rank #1 (Strong Buy)

    80% confidence

  • For 2026, Insulet revenues and EPS are expected to grow 19.8% and 26.3%, respectively

    80% confidence

Data points we hold from this source

U.S. Food and Drug Administration · ai device authorizations250 devices
4 Medical Device Stocks to Buy for Healthy Returns in 2026 — Source | Via News | ViaNews EU